Overlap between functional GI disorders and other functional syndromes: What are the underlying mechanisms?

Neurogastroenterology and Motility

Volumn 24, Issue 10, 2012, Pages 895-913

  Kim, S E ^a,c   Chang, L ^a,b  

^a Oppenheimer Family Center of Neurobiology of Stress   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Chronic fatigue syndrome; Fibromyalgia; Functional dyspepsia; Interstitial cystitis painful bladder syndrome; Irritable bowel syndrome; Temporomandibular joint disorder

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

CHRONIC FATIGUE SYNDROME; CHRONIC STRESS; CYTOKINE RELEASE; DISEASE ASSOCIATION; DYSPEPSIA; FIBROMYALGIA; FUNCTIONAL NEUROIMAGING; GASTROINTESTINAL DISEASE; HEREDITY; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE DYSREGULATION; INFECTION COMPLICATION; INFLAMMATION; INNATE IMMUNITY; INTERSTITIAL CYSTITIS; IRRITABLE COLON; NEUROENDOCRINE SYSTEM; NOCICEPTION; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; TEMPOROMANDIBULAR JOINT DISORDER;

HUMANS; IRRITABLE BOWEL SYNDROME; SOMATOFORM DISORDERS;

EID: 84866315222     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2012.01993.x     Document Type: Review

References (229)

1. Mayer EA, Tillisch K. The brain-gut axis in abdominal pain syndromes. Annu Rev Med 2011; 62: 381-96.
2. Posserud I, Agerforz P, Ekman R, Bjornsson ES, Abrahamsson H, Simren M. Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress. Gut 2004; 53: 1102-8.
3. Pimentel M. The prevalence of small intestinal bacterial overgrowth in irritable bowel syndrome: IBS vs healthy controls (not historical definitions). Gut 2008; 57: 1334-5.
4. Spiller RC, Jenkins D, Thornley JP et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000; 47: 804-11.
5. Barbara G, Cremon C, Carini G et al. The immune system in irritable bowel syndrome. J Neurogastroenterol Motil 2011; 17: 349-59.
6. Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology 2002; 123: 2108-31.
7. Van Oudenhove L, Vandenberghe J, Vos R, Holvoet L, Tack J. Factors associated with co-morbid irritable bowel syndrome and chronic fatigue-like symptoms in functional dyspepsia. Neurogastroenterol Motil 2011; 23: 524-e202.
8. Suzuki H, Hibi T. Overlap syndrome of functional dyspepsia and irritable bowel syndrome - are both diseases mutually exclusive?. J Neurogastroenterol Motil 2011; 17: 360-5.
9. Aaron LA, Burke MM, Buchwald D. Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. Arch Intern Med 2000; 160: 221-7.
10. Whitehead WE, Palsson O, Jones KR. Systemic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 2002; 122: 1140-56.
11. Gordon AS, Panahian-Jand M, McComb F, Melegari C, Sharp S. Characteristics of women with vulvar pain disorders: responses to a Web-based survey. J Sex Marital Ther 2003; 29(Suppl. 1): 45-58.
12. Wu EQ, Birnbaum H, Mareva M et al. Interstitial Cystitis: cost, treatment and co-morbidities in an employed population. Pharmacoeconomics 2006; 24: 55-65.
13. Vege SS, Locke GR, 3rd, Weaver AL, Farmer SA, Melton LJ, 3rd, Talley NJ. Functional gastrointestinal disorders among people with sleep disturbances: a population-based study. Mayo Clin Proc 2004; 79: 1501-6.
14. Whorwell PJ, McCallum M, Creed FH, Roberts CT. Non-colonic features of irritable bowel syndrome. Gut 1986; 27: 37-40.
15. Goldsmith G, Levin JS. Effect of sleep quality on symptoms of irritable bowel syndrome. Dig Dis Sci 1993; 38: 1809-14.
16. Mahadeva S, Goh KL. Anxiety, depression and quality of life differences between functional and organic dyspepsia. J Gastroenterol Hepatol 2011; 26(Suppl. 3): 49-52.
17. da Silva RA, Pinheiro RT, Horta BL, Moraes I, Faria AD. [Functional dyspepsia and depression as an associated factor]. Arq Gastroenterol 2006; 43: 293-8.
18. Thijssen AY, Jonkers DM, Leue C et al. Dysfunctional cognitions, anxiety and depression in irritable bowel syndrome. J Clin Gastroenterol 2010; 44: e236-41.
19. Fietta P, Manganelli P. Fibromyalgia and psychiatric disorders. Acta Biomed 2007; 78: 88-95.
20. Cohen H, Neumann L, Haiman Y, Matar MA, Press J, Buskila D. Prevalence of post-traumatic stress disorder in fibromyalgia patients: overlapping syndromes or post-traumatic fibromyalgia syndrome?. Semin Arthritis Rheum 2002; 32: 38-50.
21. Cella M, White PD, Sharpe M, Chalder T. Cognitions, behaviours and co-morbid psychiatric diagnoses in patients with chronic fatigue syndrome. Psychol Med 2012; 9: 1-6.
22. Dansie EJ, Furberg H, Afari N et al. Conditions comorbid with chronic fatigue in a population-based sample. Psychosomatics 2012; 53: 44-50.
23. Gallagher RM, Marbach JJ, Raphael KG, Dohrenwend BP, Cloitre M. Is major depression comorbid with temporomandibular pain and dysfunction syndrome? A pilot study. Clin J Pain 1991; 7: 219-25.
24. Clemens JQ, Brown SO, Calhoun EA. Mental health diagnoses in patients with interstitial cystitis/painful bladder syndrome and chronic prostatitis/chronic pelvic pain syndrome: a case/control study. J Urol 2008; 180: 1378-82.
25. Watkins KE, Eberhart N, Hilton L et al. Depressive disorders and panic attacks in women with bladder pain syndrome/interstitial cystitis: a population-based sample. Gen Hosp Psychiatry 2011; 33: 143-9.
26. Henningsen P, Derra C, Turp JC, Hauser W. [Functional somatic pain syndromes: summary of hypotheses of their overlap and etiology]. Schmerz 2004; 18: 136-40.
27. Lee OY, Mayer EA, Schmulson M, Chang L, Naliboff B. Gender-related differences in IBS symptoms. Am J Gastroenterol 2001; 96: 2184-93.
28. Heitkemper M, Jarrett M. Irritable bowel syndrome: does gender matter?. J Psychosom Res 2008; 64: 583-7.
29. Lange M, Karpinski N, Krohn-Grimberghe B, Petermann F. [Patients with fibromyalgia: gender differences]. Schmerz 2010; 24: 262-6.
30. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006; 130: 1480-91.
31. Adeyemo MA, Spiegel BM, Chang L. Meta-analysis: do irritable bowel syndrome symptoms vary between men and women?. Aliment Pharmacol Ther 2010; 32: 738-55.
32. Kleibeuker JH, Thijs JC. Functional dyspepsia. Curr Opin Gastroenterol 2004; 20: 546-50.
33. Talley NJ, Choung RS. Whither dyspepsia? A historical perspective of functional dyspepsia, and concepts of pathogenesis and therapy in 2009. J Gastroenterol Hepatol 2009; 24(Suppl. 3): S20-8.
34. Mahadeva S, Goh KL. Epidemiology of functional dyspepsia: a global perspective. World J Gastroenterol 2006; 12: 2661-6.
35. Mearin F, Calleja JL. Defining functional dyspepsia. Rev Esp Enferm Dig 2012; 103: 640-7.
36. Talley NJ, Vakil N. Guidelines for the management of dyspepsia. Am J Gastroenterol 2005; 100: 2324-37.
37. Wolfe F, Clauw DJ, Fitzcharles MA et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res 2010; 62: 600-10.
38. Raspe H. [Rheumatism epidemiology in Europe]. Soz Praventivmed 1992; 37: 168-78.
39. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995; 38: 19-28.
40. Wadhwa S, Kapila S. TMJ disorders: future innovations in diagnostics and therapeutics. J Dent Educ 2008; 72: 930-47.
41. Von Korff M, Dworkin SF, Le Resche L, Kruger A. An epidemiologic comparison of pain complaints. Pain 1988; 32: 173-83.
42. Dworkin SF, Huggins KH, Wilson L et al. A randomized clinical trial using research diagnostic criteria for temporomandibular disorders-axis II to target clinic cases for a tailored self-care TMD treatment program. J Orofac Pain 2002; 16: 48-63.
43. Carmeli E, Sheklow SL, Blommenfeld I. Comparative Study of Repositioning Splint Therapy and Passive Manual Range of Motion Techniques for Anterior Displaced Temporomandibular Discs with Unstable Excursive Reduction. Physiotherapy 2001; 2001: 26-36.
44. Gillenwater JY, Wein AJ. Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28-29, 1987. J Urol 1988; 140: 203-6.
45. Abrams P, Cardozo L, Fall M et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Am J Obstet Gynecol 2002; 187: 116-26.
46. Moutzouris DA, Falagas ME. Interstitial cystitis: an unsolved enigma. Clin J Am Soc Nephrol 2009; 4: 1844-57.
47. Avellaneda Fernandez A, Perez Martin A, Izquierdo Martinez M et al. Chronic fatigue syndrome: aetiology, diagnosis and treatment. BMC psychiatry 2009; 9(Suppl. 1): S1.
48. Fluge O, Bruland O, Risa K et al. Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study. PLoS One 2011; 6: e26358.
49. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 1994; 121: 953-9.
50. Zhou Q, Verne GN. New insights into visceral hypersensitivity--clinical implications in IBS. Nat Rev Gastroenterol Hepatol 2011; 8: 349-55.
51. Naliboff BD, Munakata J, Fullerton S et al. Evidence for two distinct perceptual alterations in irritable bowel syndrome. Gut 1997; 41: 505-12.
52. Zhou Q, Fillingim RB, Riley JL, 3rd, Malarkey WB, Verne GN. Central and peripheral hypersensitivity in the irritable bowel syndrome. Pain 2010; 148: 454-61.
53. Naliboff BD, Derbyshire SW, Munakata J et al. Cerebral activation in patients with irritable bowel syndrome and control subjects during rectosigmoid stimulation. Psychosom Med 2001; 63: 365-75.
54. Dorn SD, Palsson OS, Thiwan SI et al. Increased colonic pain sensitivity in irritable bowel syndrome is the result of an increased tendency to report pain rather than increased neurosensory sensitivity. Gut 2007; 56: 1202-9.
55. Caldarella MP, Giamberardino MA, Sacco F et al. Sensitivity disturbances in patients with irritable bowel syndrome and fibromyalgia. Am J Gastroenterol 2006; 101: 2782-9.
56. Chang L, Mayer EA, Johnson T, FitzGerald LZ, Naliboff B. Differences in somatic perception in female patients with irritable bowel syndrome with and without fibromyalgia. Pain 2000; 84: 297-307.
57. Casellas F, Lopez-Vivancos J, Badia X, Vilaseca J, Malagelada JR. Impact of surgery for Crohn's disease on health-related quality of life. Am J Gastroenterol 2000; 95: 177-82.
58. Verne GN, Himes NC, Robinson ME et al. Central representation of visceral and cutaneous hypersensitivity in the irritable bowel syndrome. Pain 2003; 103: 99-110.
59. Moshiree B, Price DD, Robinson ME, Gaible R, Verne GN. Thermal and visceral hypersensitivity in irritable bowel syndrome patients with and without fibromyalgia. Clin J Pain 2007; 23: 323-30.
60. Mertz H, Fullerton S, Naliboff B, Mayer EA. Symptoms and visceral perception in severe functional and organic dyspepsia. Gut 1998; 42: 814-22.
61. Corsetti M, Caenepeel P, Fischler B, Janssens J, Tack J. Impact of coexisting irritable bowel syndrome on symptoms and pathophysiological mechanisms in functional dyspepsia. Am J Gastroenterol 2004; 99: 1152-9.
62. Tack J, Caenepeel P, Corsetti M, Janssens J. Role of tension receptors in dyspeptic patients with hypersensitivity to gastric distention. Gastroenterology 2004; 127: 1058-66.
63. Holtmann G, Goebell H, Talley NJ. Functional dyspepsia and irritable bowel syndrome: is there a common pathophysiological basis?. Am J Gastroenterol 1997; 92: 954-9.
64. Staud R. Evidence of involvement of central neural mechanisms in generating fibromyalgia pain. Curr Rheumatol Rep 2002; 4: 299-305.
65. Wilbarger JL, Cook DB. Multisensory hypersensitivity in women with fibromyalgia: implications for well being and intervention. Arch Phys Med Rehabil 2011; 92: 653-6.
66. Diers M, Koeppe C, Yilmaz P et al. Pain ratings and somatosensory evoked responses to repetitive intramuscular and intracutaneous stimulation in fibromyalgia syndrome. J Clin Neurophysiol 2008; 25: 153-60.
67. Gibson SJ, Littlejohn GO, Gorman MM, Helme RD, Granges G. Altered heat pain thresholds and cerebral event-related potentials following painful CO2 laser stimulation in subjects with fibromyalgia syndrome. Pain 1994; 58: 185-93.
68. Chun A, Desautels S, Slivka A et al. Visceral algesia in irritable bowel syndrome, fibromyalgia, and sphincter of oddi dysfunction, type III. Dig Dis Sci 1999; 44: 631-6.
69. Staud R, Nagel S, Robinson ME, Price DD. Enhanced central pain processing of fibromyalgia patients is maintained by muscle afferent input: a randomized, double-blind, placebocontrolled study. Pain 2009; 145: 96-104.
70. Greenspan JD, Slade GD, Bair E et al. Pain sensitivity risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case control study. J Pain 2011; 12: T61-74.
71. Maixner W, Fillingim R, Booker D, Sigurdsson A. Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain. Pain 1995; 63: 341-51.
72. Ness TJ, Powell-Boone T, Cannon R, Lloyd LK, Fillingim RB. Psychophysical evidence of hypersensitivity in subjects with interstitial cystitis. J Urol 2005; 173: 1983-7.
73. Mukerji G, Waters J, Chessell IP, Bountra C, Agarwal SK, Anand P. Pain during ice water test distinguishes clinical bladder hypersensitivity from overactivity disorders. BMC Urol 2006; 6: 31.
74. Buchwald D. Fibromyalgia and chronic fatigue syndrome: similarities and differences. Rheum Dis Clin North Am 1996; 22: 219-43.
75. Nijs J, Meeus M, Van Oosterwijck J et al. In the mind or in the brain? Scientific evidence for central sensitisation in chronic fatigue syndrome. Eur J Clin Invest 2012; 42: 203-12.
76. Vecchiet J, Cipollone F, Falasca K et al. Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome. Neurosci Lett 2003; 335: 151-4.
77. Whiteside A, Hansen S, Chaudhuri A. Exercise lowers pain threshold in chronic fatigue syndrome. Pain 2004; 109: 497-9.
78. Costa DC, Tannock C, Brostoff J. Brainstem perfusion is impaired in chronic fatigue syndrome. QJM 1995; 88: 767-73.
79. Tirelli U, Chierichetti F, Tavio M et al. Brain positron emission tomography (PET) in chronic fatigue syndrome: preliminary data. Am J Med 1998; 105: 54S-8S.
80. Mountz JM, Bradley LA, Modell JG et al. Fibromyalgia in women Abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels. Arthritis Rheum 1995; 38: 926-38.
81. Ohman L, Simren M. New insights into the pathogenesis and pathophysiology of irritable bowel syndrome. Dig Liver Dis 2007; 39: 201-15.
82. Rapps N, van Oudenhove L, Enck P, Aziz Q. Brain imaging of visceral functions in healthy volunteers and IBS patients. J Psychosom Res 2008; 64: 599-604.
83. Aziz Q, Schnitzler A, Enck P. Functional neuroimaging of visceral sensation. J Clin Neurophysiol 2000; 17: 604-12.
84. Ducrotte P. [Irritable bowel syndrome: from the gut to the brain-gut]. Gastroenterol Clin Biol 2009; 33: 703-12.
85. Mayer EA, Berman S, Suyenobu B et al. Differences in brain responses to visceral pain between patients with irritable bowel syndrome and ulcerative colitis. Pain 2005; 115: 398-409.
86. Mertz H, Morgan V, Tanner G et al. Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention. Gastroenterology 2000; 118: 842-8.
87. Mayer EA, Naliboff BD, Craig AD. Neuroimaging of the brain-gut axis: from basic understanding to treatment of functional GI disorders. Gastroenterology 2006; 131: 1925-42.
88. Larsson MB, Tillisch K, Craig AD et al. Brain responses to visceral stimuli reflect visceral sensitivity thresholds in patients with irritable bowel syndrome. Gastroenterology 2012; 142: 463-72.
89. Mearin F, Cucala M, Azpiroz F, Malagelada JR. The origin of symptoms on the brain-gut axis in functional dyspepsia. Gastroenterology 1991; 101: 999-1006.
90. Chua AS. Reassessment of functional dyspepsia: a topic review. World J Gastroenterol 2006; 12: 2656-9.
91. Van Oudenhove L, Vandenberghe J, Dupont P et al. Abnormal regional brain activity during rest and (anticipated) gastric distension in functional dyspepsia and the role of anxiety: a H(2)(15)O-PET study. Am J Gastroenterol 2010; 105: 913-24.
92. Vandenberghe J, Dupont P, Van Oudenhove L et al. Regional cerebral blood flow during gastric balloon distention in functional dyspepsia. Gastroenterology 2007; 132: 1684-93.
93. Zeng F, Qin W, Liang F et al. Abnormal resting brain activity in patients with functional dyspepsia is related to symptom severity. Gastroenterology 2011; 141: 499-506.
94. Caro XJ, Winter EF, Dumas AJ. A subset of fibromyalgia patients have findings suggestive of chronic inflammatory demyelinating polyneuropathy and appear to respond to IVIg. Rheumatology 2008; 47: 208-11.
95. Gracely RH, Petzke F, Wolf JM, Clauw DJ. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 2002; 46: 1333-43.
96. Cook DB, Lange G, Ciccone DS, Liu WC, Steffener J, Natelson BH. Functional imaging of pain in patients with primary fibromyalgia. J Rheumatol 2004; 31: 364-78.
97. Chang L, Berman S, Mayer EA et al. Brain responses to visceral and somatic stimuli in patients with irritable bowel syndrome with and without fibromyalgia. Am J Gastroenterol 2003; 98: 1354-61.
98. Ceko M, Bushnell MC, Gracely RH. Neurobiology underlying fibromyalgia symptoms. Pain Res Treat 2012; 2012: 585419.
99. Gerstner G, Ichesco E, Quintero A, Schmidt-Wilcke T. Changes in regional gray and white matter volume in patients with myofascial-type temporomandibular disorders: a voxel-based morphometry study. J Orofacl Pain 2011; 25: 99-106.
100. Jiang T, Li J, Jin Z, Wang YW, Feng HL, Ishikawa T. Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = [Comparison of atypical orofacial pain and temporomandibular disorders synovitis pain processing in the human brain using functional magnetic resonance imaging]. Chin J Stomatol 2006; 41: 670-3.
101. Alonso AA, Koutlas IG, Leuthold AC, Lewis SM, Georgopoulos AP. Cortical processing of facial tactile stimuli in temporomandibular disorder as revealed by magnetoencephalography. Exp Brain Res 2010; 204: 33-45.
102. Twiss C, Kilpatrick L, Craske M et al. Increased startle responses in interstitial cystitis: evidence for central hyperresponsiveness to visceral related threat. J Urol 2009; 181: 2127-33.
103. Naliboff BD, Waters AM, Labus JS et al. Increased acoustic startle responses in IBS patients during abdominal and nonabdominal threat. Psychosom Med 2008; 70: 920-7.
104. MacHale SM, Lawrie SM, Cavanagh JT et al. Cerebral perfusion in chronic fatigue syndrome and depression. Br J Psychiatry 2000; 176: 550-6.
105. Puri BK, Jakeman PM, Agour M et al. Regional grey and white matter volumetric changes in myalgic encephalomyelitis (chronic fatigue syndrome): a voxel-based morphometry 3-T MRI study. Br J Radiol 2012; 85: e270-3.
106. Perrin R, Embleton K, Pentreath VW, Jackson A. Longitudinal MRI shows no cerebral abnormality in chronic fatigue syndrome. Br J Radiol 2010; 83: 419-23.
107. Barbara G, Wang B, Stanghellini V et al. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 2007; 132: 26-37.
108. Barbara G, Stanghellini V, De Giorgio R et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004; 126: 693-702.
109. Buhner S, Li Q, Vignali S et al. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome. Gastroenterology 2009; 137: 1425-34.
110. Klooker TK, Braak B, Koopman KE et al. The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome. Gut 2010; 59: 1213-21.
111. Chang L, Adeyemo M, Karagiannidis I et al. Serum and colonic mucosal immune markers in irritable bowel syndrome. Am J Gastroenterol 2012; 107: 262-72.
112. Scully P, McKernan DP, Keohane J et al. Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal co-morbidity. Am J Gastroenterol 2010; 105: 2235-43.
113. McKernan DP, Nolan A, Brint EK et al. Toll-like receptor mRNA expression is selectively increased in the colonic mucosa of two animal models relevant to irritable bowel syndrome. PLoS One 2009; 4: e8226.
114. Brint EK, MacSharry J, Fanning A, Shanahan F, Quigley EM. Differential expression of toll-like receptors in patients with irritable bowel syndrome. Am J Gastroenterol 2011; 106: 329-36.
115. Langhorst J, Junge A, Rueffer A et al. Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome. Am J Gastroenterol 2009; 104: 404-10.
116. Walker MM, Warwick A, Ung C, Talley NJ. The role of eosinophils and mast cells in intestinal functional disease. Curr Gastroenterol Rep 2011; 13: 323-30.
117. Lee KJ, Tack J. Duodenal implications in the pathophysiology of functional dyspepsia. J Neurogastroenterol Motil 2010; 16: 251-7.
118. Talley NJ, Walker MM, Aro P et al. Non-ulcer dyspepsia and duodenal eosinophilia: an adult endoscopic population-based case-control study. Clin Gastroenterol Hepatol 2007; 5: 1175-83.
119. Walker MM, Salehian SS, Murray CE et al. Implications of eosinophilia in the normal duodenal biopsy - an association with allergy and functional dyspepsia. Aliment Pharmacol Ther 2010; 31: 1229-36.
120. Kindt S, Tertychnyy A, de Hertogh G, Geboes K, Tack J. Intestinal immune activation in presumed post-infectious functional dyspepsia. Neurogastroenterol Motil 2009; 21: 832-e56.
121. Blanco I, Beritze N, Arguelles M et al. Abnormal overexpression of mastocytes in skin biopsies of fibromyalgia patients. Clin Rheumatol 2010; 29: 1403-12.
122. Lucas HJ, Brauch CM, Settas L, Theoharides TC. Fibromyalgia--new concepts of pathogenesis and treatment. Int J Immunopathol Pharmacol 2006; 19: 5-10.
123. Ross RL, Jones KD, Bennett RM, Ward RL, Druker BJ, Wood LJ. Preliminary Evidence of Increased Pain and Elevated Cytokines in Fibromyalgia Patients with Defective Growth Hormone Response to Exercise. Open Immunol J 2010; 3: 9-18.
124. Wallace DJ, Linker-Israeli M, Hallegua D, Silverman S, Silver D, Weisman MH. Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study. Rheumatology 2001; 40: 743-9.
125. Wang H, Buchner M, Moser MT, Daniel V, Schiltenwolf M. The role of IL-8 in patients with fibromyalgia: a prospective longitudinal study of 6months. Clin J Pain 2009; 25: 1-4.
126. Togo F, Natelson BH, Adler GK et al. Plasma cytokine fluctuations over time in healthy controls and patients with fibromyalgia. Exp Biol Med 2009; 234: 232-40.
127. Garcia-Lozano JR, Capilla-Sevilla C, Garcia-Lopez O, Moreno-Gallego I. Correlation between cytokines and anxious-depressive symptoms in patients with fibromyalgia. Reumatol Clin 2008; 4: 136-9.
128. Chang H, Israel H. Analysis of inflammatory mediators in temporomandibular joint synovial fluid lavage samples of symptomatic patients and asymptomatic controls. J Oral Maxillofac Surg 2005; 63: 761-5.
129. Kaneyama K, Segami N, Sun W, Sato J, Fujimura K. Levels of soluble cytokine factors in temporomandibular joint effusions seen on magnetic resonance images. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 99: 411-8.
130. Theoharides TC, Pang X, Letourneau R, Sant GR. Interstitial cystitis: a neuroimmunoendocrine disorder. Ann N Y Acad Sci 1998; 840: 619-34.
131. Sant GR, Kempuraj D, Marchand JE, Theoharides TC. The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis. Urology 2007; 69: 34-40.
132. Larsen S, Thompson SA, Hald T et al. Mast cells in interstitial cystitis. Br J Urol 1982; 54: 283-6.
133. Larsen MS, Mortensen S, Nordling J, Horn T. Quantifying mast cells in bladder pain syndrome by immunohistochemical analysis. BJU Int 2008; 102: 204-7.;discussion 207.
134. Feltis JT, Perez-Marrero R, Emerson LE. Increased mast cells of the bladder in suspected cases of interstitial cystitis: a possible disease marker. J Urol 1987; 138: 42-3.
135. Park CS, Bochner BS. Potential targeting of siglecs, mast cell inhibitory receptors, in interstitial cystitis. Int Neurourol J 2011; 15: 61-3.
136. Aoki T, Miyakoshi H, Usuda Y, Herberman RB. Low NK syndrome and its relationship to chronic fatigue syndrome. Clin Immunol Immunopathol 1993; 69: 253-65.
137. Moss RB, Mercandetti A, Vojdani A. TNF-alpha and chronic fatigue syndrome. J Clin Immunol 1999; 19: 314-6.
138. Patarca R. Cytokines and chronic fatigue syndrome. Ann N Y Acad Sci 2001; 933: 185-200.
139. Raison CL, Lin JM, Reeves WC. Association of peripheral inflammatory markers with chronic fatigue in a population-based sample. Brain Behav Immun 2009; 23: 327-37.
140. Nater UM, Youngblood LS, Jones JF et al. Alterations in diurnal salivary cortisol rhythm in a population-based sample of cases with chronic fatigue syndrome. Psychosom Med 2008; 70: 298-305.
141. Berstad A, Undseth R, Lind R, Valeur J. Functional bowel symptoms, fibromyalgia and fatigue: A food-induced triad?. Scand J Gastroenterol 2012;doi:10.3109/00365521.2012.690045.
142. Dunlop SP, Jenkins D, Neal KR et al. Randomized, double-blind, placebo-controlled trial of prednisolone in post-infectious irritable bowel syndrome. Aliment Pharmacol Ther 2003; 18: 77-84.
143. Schwille-Kiuntke J, Frick JS, Zanger P, Enck P. Post-infectious irritable bowel syndrome--a review of the literature. Z Gastroenterol 2011; 49: 997-1003.
144. Porter CK, Gormley R, Tribble DR, Cash BD, Riddle MS. The Incidence and gastrointestinal infectious risk of functional gastrointestinal disorders in a healthy US adult population. Am J Gastroenterol 2011; 106: 130-8.
145. Wood NJ. Infection: Giardia lamblia is associated with an increased risk of both IBS and chronic fatigue that persists for at least 3 years. Nat Rev Gastroenterol Hepatol 2011; 8: 597.
146. Spiller RC. Inflammation as a basis for functional GI disorders. Best Pract Res Clin Gastroenterol 2004; 18: 641-61.
147. Suzuki H, Matsuzaki J, Hibi T. What is the difference between Helicobacter pylori-associated dyspepsia and functional dyspepsia?. J Neurogastroenterol Motil 2011; 17: 124-30.
148. Hanevik K, Dizdar V, Langeland N, Hausken T. Development of functional gastrointestinal disorders after Giardia lamblia infection. BMC Gastroenterol 2009; 9: 27.
149. Talley NJ, Janssens J, Lauritsen K, Racz I, Bolling-Sternevald E. Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group. BMJ 1999; 318: 833-7.
150. Blum AL, Talley NJ, O'Morain C et al. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group. N Engl J Med 1998; 339: 1875-81.
151. Mearin F, Perez-Oliveras M, Perello A et al. Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study. Gastroenterology 2005; 129: 98-104.
152. Ablin JN, Shoenfeld Y, Buskila D. Fibromyalgia, infection and vaccination: two more parts in the etiological puzzle. J Autoimmun 2006; 27: 145-52.
153. Simms RW, Zerbini CA, Ferrante N, Anthony J, Felson DT, Craven DE. Fibromyalgia syndrome in patients infected with human immunodeficiency virus The Boston City Hospital Clinical AIDS Team. Am J Med 1992; 92: 368-74.
154. Buskila D, Shnaider A, Neumann L et al. Musculoskeletal manifestations and autoantibody profile in 90 hepatitis C virus infected Israeli patients. Semin Arthritis Rheum 1998; 28: 107-13.
155. Dinerman H, Steere AC. Lyme disease associated with fibromyalgia. Ann Intern Med 1992; 117: 281-5.
156. Buyukkose M, Kozanoglu E, Basaran S, Bayramoglu O, Yarkin F. Seroprevalence of parvovirus B19 in fibromyalgia syndrome. Clin Rheumatol 2009; 28: 305-9.
157. Narvaez J, Nolla JM, Valverde-Garcia J. Lack of association of fibromyalgia with hepatitis C virus infection. J Rheumatol 2005; 32: 1118-21.
158. Palazzi C, D'Amico E, D'Angelo S, Nucera A, Petricca A, Olivieri I. Hepatitis C virus infection in Italian patients with fibromyalgia. Clin Rheumatol 2008; 27: 101-3.
159. Ranganathan LK, Mathew GC, Gandhi S, Manohar M. Tuberculosis of temporomandibular joint presenting as swelling in the preauricular region. J Oral Maxillofac Surg 2012; 70: e28-31.
160. Helbling CA, Lieger O, Smolka W, Iizuka T, Kuttenberger J. Primary tuberculosis of the TMJ: presentation of a case and literature review. Int J Oral Maxillofac Surg 2010; 39: 834-8.
161. Gandhi S, Ranganathan LK, Bither S, Koshy G. Tuberculosis of temporomandibular joint: a case report. J Oral Maxillofac Surg 2011; 69: e128-30.
162. Allori AC, Chang CC, Farina R, Grayson BH, Warren SM, McCarthy JG. Current concepts in pediatric temporomandibular joint disorders: Part 1. Etiology, epidemiology, and classification. Plast Reconstr Surg 2010; 126: 1263-75.
163. Fiorentino PM, Piancino MG, Debernardi C, Attard N. Temporomandibular joint disorders during HIV infection: a case report. J Orofac Pain 2009; 23: 174-6.
164. Warren JW, Brown V, Jacobs S, Horne L, Langenberg P, Greenberg P. Urinary tract infection and inflammation at onset of interstitial cystitis/painful bladder syndrome. Urology 2008; 71: 1085-90.
165. Berger RE. Re: Prevalence and Impact of Bacteriuria and/or Urinary Tract Infection in Interstitial Cystitis/Painful Bladder Syndrome. J Urol 2011; 185: 155.
166. Li GZ, Zhang N, Du P et al. Risk factors for interstitial cystitis/painful bladder syndrome in patients with lower urinary tract symptoms: a Chinese multi-center study. Chin Med J 2010; 123: 2842-6.
167. Stanford E, McMurphy C. There is a low incidence of recurrent bacteriuria in painful bladder syndrome/interstitial cystitis patients followed longitudinally. Int Urogynecol J Pelvic Floor Dysfunct 2007; 18: 551-4.
168. Komaroff AL, Cho TA. Role of infection and neurologic dysfunction in chronic fatigue syndrome. Semin Neurol 2011; 31: 325-37.
169. Chia J, Chia A, Voeller M, Lee T, Chang R. Acute enterovirus infection followed by myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and viral persistence. J Clin Pathol 2010; 63: 165-8.
170. Nijs J, Nicolson GL, De Becker P, Coomans D, De Meirleir K. High prevalence of Mycoplasma infections among European chronic fatigue syndrome patients Examination of four Mycoplasma species in blood of chronic fatigue syndrome patients. FEMS Immunol Med Microbiol 2002; 34: 209-14.
171. Bansal AS, Bradley AS, Bishop KN, Kiani-Alikhan S, Ford B. Chronic fatigue syndrome, the immune system and viral infection. Brain Behav Immun 2012; 26: 24-31.
172. Mikovits JA, Lombardi VC, Pfost MA, Hagen KS, Ruscetti FW. Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Virulence 2010; 1: 386-90.
173. Naess H, Nyland M, Hausken T, Follestad I, Nyland HI. Chronic fatigue syndrome after Giardia enteritis: clinical characteristics, disability and long-term sickness absence. BMC Gastroenterol 2012; 12: 13.
174. Wensaas KA, Langeland N, Hanevik K, Morch K, Eide GE, Rortveit G. Irritable bowel syndrome and chronic fatigue 3years after acute giardiasis: historic cohort study. Gut 2012; 61: 214-9.
175. Henrich TJ, Li JZ, Felsenstein D et al. Xenotropic murine leukemia virus-related virus prevalence in patients with chronic fatigue syndrome or chronic immunomodulatory conditions. J Infect Dis 2010; 202: 1478-81.
176. Chang L. The role of stress on physiologic responses and clinical symptoms in irritable bowel syndrome. Gastroenterology 2011; 140: 761-5.
177. Chang L, Sundaresh S, Elliott J et al. Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome. Neurogastroenterol Motil 2009; 21: 149-59.
178. Videlock EJ, Adeyemo M, Licudine A et al. Childhood trauma is associated with hypothalamic-pituitary-adrenal axis responsiveness in irritable bowel syndrome. Gastroenterology 2009; 137: 1954-62.
179. Bohmelt AH, Nater UM, Franke S, Hellhammer DH, Ehlert U. Basal and stimulated hypothalamic-pituitary-adrenal axis activity in patients with functional gastrointestinal disorders and healthy controls. Psychosom Med 2005; 67: 288-94.
180. Mutsuura H, Kanbara K, Fukunaga M et al. Depression and anxiety correlate differently with salivary free cortisol in the morning in patients with functional somatic syndrome. Appl Psychophysiol Biofeedback 2009; 34: 291-8.
181. Crofford LJ. The hypothalamic-pituitary-adrenal stress axis in fibromyalgia and chronic fatigue syndrome. Z Rheumatol 1998; 57(Suppl. 2): 67-71.
182. Riva R, Mork PJ, Westgaard RH, Ro M, Lundberg U. Fibromyalgia syndrome is associated with hypocortisolism. Int J Behav Med 2010; 17: 223-33.
183. Tak LM, Cleare AJ, Ormel J et al. Meta-analysis and meta-regression of
184. Tanriverdi F, Karaca Z, Unluhizarci K, Kelestimur F. The hypothalamo-pituitary-adrenal axis in chronic fatigue syndrome and fibromyalgia syndrome. Stress 2007; 10: 13-25.
185. Yang D, Ye L. Temporomandibular disorders and declarative memory. Med Hypotheses 2011; 76: 723-5.
186. Da Silva Andrade A, Gamero GH, Pereira LJ, Junqueira Zanin IC, Gaviao MB. Salivary cortisol levels in young adults with temporomandibular disorders. Minerva Stomatol 2008; 57: 109-16.
187. Nilsson AM, Dahlstrom L. Perceived symptoms of psychological distress and salivary cortisol levels in young women with muscular or disk-related temporomandibular disorders. Acta Odontol Scand 2010; 68: 284-8.
188. Lutgendorf SK, Kreder KJ, Rothrock NE et al. Diurnal cortisol variations and symptoms in patients with interstitial cystitis. J Urol 2002; 167: 1338-43.
189. Buffington CA. Comorbidity of interstitial cystitis with other unexplained clinical conditions. J Urol 2004; 172: 1242-8.
190. Westropp JL, Welk KA, Buffington CA. Small adrenal glands in cats with feline interstitial cystitis. J Urol 2003; 170: 2494-7.
191. Papadopoulos AS, Cleare AJ. Hypothalamic-pituitary-adrenal axis dysfunction in chronic fatigue syndrome. Nat Rev Endocrinol 2011; 8: 22-32.
192. Demitrack MA, Dale JK, Straus SE et al. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab 1991; 73: 1224-34.
193. Saito YA, Mitra N, Mayer EA. Genetic approaches to functional gastrointestinal disorders. Gastroenterology 2010; 138: 1276-85.
194. Camilleri M. Evolving concepts of the pathogenesis of irritable bowel syndrome: to treat the brain or the gut?. J Pediatr Gastroenterol Nutr 2009; 48(Suppl. 2): S46-8.
195. Schmulson M, Pulido-London D, Rodriguez O et al. Lower Serum IL-10 Is an Independent Predictor of IBS Among Volunteers in Mexico. Am J Gastroenterol 2012; 107: 747-53.
196. Saito YA. The role of genetics in IBS. Gastroenterol Clin North Am 2011; 40: 45-67.
197. Arisawa T, Tahara T, Shibata T et al. Genetic polymorphisms of molecules associated with inflammation and immune response in Japanese subjects with functional dyspepsia. Int J Mol Med 2007; 20: 717-23.
198. Holtmann G, Talley NJ. Hypothesis driven research and molecular mechanisms in functional dyspepsia: the beginning of a beautiful friendship in research and practice? Am J Gastroenterol 2006; 101: 593-5.
199. Finan PH, Zautra AJ, Davis MC, Lemery-Chalfant K, Covault J, Tennen H. Genetic influences on the dynamics of pain and affect in fibromyalgia. Health Psychol 2010; 29: 134-42.
200. Bondy B, Spaeth M, Offenbaecher M et al. The T102C polymorphism of the 5-HT2A-receptor gene in fibromyalgia. Neurobiol Dis 1999; 6: 433-9.
201. Slade GD, Diatchenko L, Ohrbach R, Maixner W. Orthodontic Treatment, Genetic Factors and Risk of Temporomandibular Disorder. Semin Orthod 2008; 14: 146-56.
202. Diatchenko L, Anderson AD, Slade GD et al. Three major haplotypes of the beta2 adrenergic receptor define psychological profile, blood pressure, and the risk for development of a common musculoskeletal pain disorder. Am J Med Genet B Neuropsychiatr Genet 2006; 141B: 449-62.
203. Kang SC, Lee DG, Choi JH, Kim ST, Kim YK, Ahn HJ. Association between estrogen receptor polymorphism and pain susceptibility in female temporomandibular joint osteoarthritis patients. Int J Oral Maxillofac Surg 2007; 36: 391-4.
204. Warren JW, Keay SK, Meyers D, Xu J. Concordance of interstitial cystitis in monozygotic and dizygotic twin pairs. Urology 2001; 57: 22-5.
205. Light KC, White AT, Tadler S, Iacob E, Light AR. Genetics and Gene Expression Involving Stress and Distress Pathways in Fibromyalgia with and without Comorbid Chronic Fatigue Syndrome. Pain Res Treat 2012; 2012: 427869.
206. Smith AK, Fang H, Whistler T, Unger ER, Rajeevan MS. Convergent genomic studies identify association of GRIK2 and NPAS2 with chronic fatigue syndrome. Neuropsychobiology 2011; 64: 183-94.
207. Pihur V, Datta S. Meta analysis of Chronic Fatigue Syndrome through integration of clinical, gene expression, SNP and proteomic data. Bioinformation 2011; 6: 120-4.
208. Kaiser J. Biomedicine. Genes and chronic fatigue: how strong is the evidence? Science 2006; 312: 669-71.
209. Buchwald D, Herrell R, Ashton S et al. A twin study of chronic fatigue. Psychosom Med 2001; 63: 936-43.
210. Walsh CM, Zainal NZ, Middleton SJ, Paykel ES. A family history study of chronic fatigue syndrome. Psychiatr Genet 2001; 11: 123-8.
211. Tack J, Talley NJ, Camilleri M et al. Functional gastroduodenal disorders. Gastroenterology 2006; 130: 1466-79.
212. Thompson WG. Irritable bowel syndrome: prevalence, prognosis and consequences. CMAJ 1986; 134: 111-3.
213. El-Serag HB, Talley NJ. Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther 2004; 19: 643-54.
214. Arnold LM, Clauw DJ, McCarberg BH. Improving the recognition and diagnosis of fibromyalgia. Mayo Clin Proc 2011; 86: 457-64.
215. Boneva RS, Maloney EM, Lin JM et al. Gynecological history in chronic fatigue syndrome: a population-based case-control study. J Womens Health 2011; 20: 21-8.
216. Poveda Roda R, Bagan JV, Diaz Fernandez JM, Hernandez Bazan S, Jimenez Soriano Y. Review of temporomandibular joint pathology Part I: classification, epidemiology and risk factors. Med Oral Patol Oral Cir Bucal 2007; 12: E292-8.
217. Nacul LC, Lacerda EM, Pheby D et al. Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in three regions of England: a repeated cross-sectional study in primary care. BMC Med 2011; 9: 91.
218. LeResche L, Mancl LA, Drangsholt MT, Huang G, Von Korff M. Predictors of onset of facial pain and temporomandibular disorders in early adolescence. Pain 2007; 129: 269-78.
219. Curhan GC, Speizer FE, Hunter DJ, Curhan SG, Stampfer MJ. Epidemiology of interstitial cystitis: a population based study. J Urol 1999; 161: 549-52.
220. Wang A, Liao X, Xiong L et al. The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria. BMC Gastroenterol 2008; 8: 43.
221. Veale D, Kavanagh G, Fielding JF, Fitzgerald O. Primary fibromyalgia and the irritable bowel syndrome: different expressions of a common pathogenetic process. Br J Rheumatol 1991; 30: 220-2.
222. Pace FMG, Bollani S, Sarzi-Puttini P, Bianchi Porro G. Visceral Sensitivity in Patients with Fibromyalgia and in Normal Patients. Gastroenterology 1997; 112: A802.
223. Sperber AD, Dekel R. Irritable Bowel Syndrome and Co-morbid Gastrointestinal and Extra-gastrointestinal Functional Syndromes. J Neurogastroenterol Motil 2010; 16: 113-9.
224. Goldenberg DL, Simms RW, Geiger A, Komaroff AL. High frequency of fibromyalgia in patients with chronic fatigue seen in a primary care practice. Arthritis Rheum 1990; 33: 381-7.
225. Gomborone JE, Gorard DA, Dewsnap PA, Libby GW, Farthing MJ. Prevalence of irritable bowel syndrome in chronic fatigue. J R Coll Physicians Lond 1996; 30: 512-3.
226. Alagiri M, Chottiner S, Ratner V, Slade D, Hanno PM. Interstitial cystitis: unexplained associations with other chronic disease and pain syndromes. Urology 1997; 49: 52-7.
227. Clemens JQ, Brown SO, Kozloff L, Calhoun EA. Predictors of symptom severity in patients with chronic prostatitis and interstitial cystitis. J Urol 2006; 175: 963-6; discussion 967.
228. Rodriguez MA, Afari N, Buchwald DS. Evidence for overlap between urological and nonurological unexplained clinical conditions. J Urol 2009; 182: 2123-31.
229. Chang L, Drossman D. Chapter 5: Irritable Bowel Syndrome and Related Functional Disorders. In: Mayer EA, Bushnell MC, eds. Functional Pain Syndromes: Presentation and Pathophysicology. Seattle, WA: IASP Press, 2009: 87-120.